Literature DB >> 22036774

Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats.

Andrea Cippitelli1, Ruslan Damadzic, Erick Singley, Annika Thorsell, Roberto Ciccocioppo, Robert L Eskay, Markus Heilig.   

Abstract

BACKGROUND: A dysregulation of the corticotropin-releasing hormone (CRH) system has been implicated in the development of excessive alcohol consumption and dependence. The aim of the present study was to evaluate whether the CRH system is also recruited when non-dependent Wistar rats escalate to high alcohol intake in the intermittent (alternate days) model of drinking.
METHODS: We compared intermittent and continuous access to 20% (v/v) alcohol in a two-bottle free choice drinking paradigm. Following a total of twenty 24-hour exposures for every experimental group, we assessed signs of alcohol withdrawal, including anxiety-like behavior and sensitivity to stress. The selective CRH1 receptor (CRH1R) antagonist antalarmin (0, 10, 20 mg/kg, i.p.) was tested on alcohol consumption.
RESULTS: Intermittent access to 20% alcohol led non-selected Wistar rats to escalate their voluntary intake to a high and stable level, whereas continuously exposed animals maintained a lower consumption. These groups did not differ in physical withdrawal signs. In addition, no differences were found when anxiogenic-like behavior was studied, neither under basal conditions or following restraint stress. Nevertheless, sensitivity to the treatment with the CRH1R antalarmin was observed since a reduction of 20% alcohol intake was found in both groups of animals regardless of the regimen of alcohol exposure. In addition, antalarmin was effective when injected to animals exposed to intermittent 10% (v/v) alcohol whereas it failed to suppress 10% continuous alcohol intake.
CONCLUSIONS: Pharmacological blockade of CRH1R reduced alcohol drinking when sustained high levels of intake were achieved suggesting that the CRH system plays a key role when high doses of ethanol are consumed by non-dependent subjects. This supports the notion that CRH system not only maintains the dependent state but also engages the transition to dependence. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036774      PMCID: PMC3242882          DOI: 10.1016/j.pbb.2011.10.016

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  51 in total

1.  Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake.

Authors:  M Foster Olive; Heather N Koenig; Michelle A Nannini; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2002-05       Impact factor: 3.533

Review 2.  The role of corticotropin-releasing factor in drug addiction.

Authors:  Z Sarnyai; Y Shaham; S C Heinrichs
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

Review 3.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

Review 4.  How does stress increase risk of drug abuse and relapse?

Authors:  R Sinha
Journal:  Psychopharmacology (Berl)       Date:  2001-10-26       Impact factor: 4.530

5.  The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats.

Authors:  D J Lodge; A J Lawrence
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

Review 6.  Alcoholism: allostasis and beyond.

Authors:  George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2003-02       Impact factor: 3.455

7.  Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence.

Authors:  Glenn R Valdez; Eric P Zorrilla; Amanda J Roberts; George F Koob
Journal:  Alcohol       Date:  2003-02       Impact factor: 2.405

8.  The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats.

Authors:  Peter W Marinelli; Douglas Funk; Walter Juzytsch; Stephen Harding; Kenner C Rice; Yavin Shaham; A D Lê
Journal:  Psychopharmacology (Berl)       Date:  2007-08-20       Impact factor: 4.530

9.  A temporal threshold for induction of persistent alcohol preference: behavioral evidence in a rat model of intermittent intoxication.

Authors:  Roberto Rimondini; Wolfgang Sommer; Markus Heilig
Journal:  J Stud Alcohol       Date:  2003-07

Review 10.  Alcohol addiction research: from animal models to clinics.

Authors:  Rainer Spanagel
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-08       Impact factor: 3.043

View more
  46 in total

1.  Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats.

Authors:  Lydia O Ayanwuyi; Serena Stopponi; Massimo Ubaldi; Andrea Cippitelli; Cinzia Nasuti; Ruslan Damadzic; Markus Heilig; Jesse Schank; Kejun Cheng; Kenner C Rice; Roberto Ciccocioppo
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

2.  Intermittent Access to Ethanol Induces Escalated Alcohol Consumption in Primates.

Authors:  S G Lindell; M L Schwandt; S J Suomi; K C Rice; M Heilig; C S Barr
Journal:  J Addict Behav Ther Rehabil       Date:  2017-04-07

Review 3.  Corticotropin releasing factor: a key role in the neurobiology of addiction.

Authors:  Eric P Zorrilla; Marian L Logrip; George F Koob
Journal:  Front Neuroendocrinol       Date:  2014-01-20       Impact factor: 8.606

4.  Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice.

Authors:  Lara S Hwa; Akiko Shimamoto; Tala Kayyali; Kevin J Norman; Rita J Valentino; Joseph F DeBold; Klaus A Miczek
Journal:  Addict Biol       Date:  2014-09-28       Impact factor: 4.280

5.  Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Andrea Cippitelli; Lydia O Ayanwuyi; Estelle Barbier; Esi Domi; Jose M Lerma-Cabrera; Francisca Carvajal; Giulia Scuppa; Hongwu Li; Massimo Ubaldi; Markus Heilig; Marisa Roberto; Roberto Ciccocioppo
Journal:  Psychopharmacology (Berl)       Date:  2014-09-27       Impact factor: 4.530

Review 6.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

Review 7.  Don't stress about CRF: assessing the translational failures of CRF1antagonists.

Authors:  Samantha R Spierling; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

8.  Effects of moderate alcohol consumption on gene expression related to colonic inflammation and antioxidant enzymes in rats.

Authors:  DawnKylee S Klarich; Jerrold Penprase; Patricia Cintora; Octavio Medrano; Danielle Erwin; Susan M Brasser; Mee Young Hong
Journal:  Alcohol       Date:  2017-04-18       Impact factor: 2.405

Review 9.  CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety.

Authors:  Kristen E Pleil; Mary Jane Skelly
Journal:  Alcohol       Date:  2018-02-02       Impact factor: 2.405

10.  Effects of moderate, voluntary ethanol consumption on the rat and human gut microbiome.

Authors:  Kassi L Kosnicki; Jerrold C Penprase; Patricia Cintora; Pedro J Torres; Greg L Harris; Susan M Brasser; Scott T Kelley
Journal:  Addict Biol       Date:  2018-05-11       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.